Neogen Corporation (NEOG) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Neogen Corporation (NEOG) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

NEOG

Market Closed

Neogen Corporation

NASDAQHealthcare Medical - Diagnostics & Research

2.92K employees

CEO: Mikhael Nassif

Founded: 1989

$9.31

+$0.00(+NaN%)

Market Cap

2.03B

Beta

1.80

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

47.1%

-8.9%

CAGR: 18.3%

Profit after direct costs

Operating Margin

1.1%

-87.8%

CAGR: -40.3%

Core business profitability

Net Margin

-122.1%

11491.6%

CAGR: N/A

Bottom line profitability

Revenue Growth

-3.2%

YoY

CAGR: 17.6%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how NEOG allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

47.1%

$421.38M

Operating Margin

1.1%

$9.42M

Net Margin

-122.1%

$-1.09B

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	468.46M	527.16M	822.45M	924.22M	894.66M	-3.2%
Cost of Revenue	(253.40M)	(284.15M)	(416.49M)	(461.59M)	(473.29M)	2.5%
Gross Profit	215.06M	243.01M	405.95M	462.63M	421.38M	-8.9%
Operating Expenses
Research & Development	(16.25M)	(17.05M)	(26.04M)	(22.48M)	(21.09M)	-6.2%
Selling, General & Administrative	(124.64M)	(167.35M)	(342.40M)	(382.76M)	(401.96M)	5.0%
General & Administrative	(51.20M)	(82.74M)	(201.18M)	(199.89M)	(218.17M)	9.1%
Selling & Marketing	(73.44M)	(84.60M)	(141.22M)	(182.87M)	(183.80M)	0.5%
Depreciation & Amortization	(21.04M)	(23.69M)	(88.38M)	(121.23M)	(125.67M)	3.7%
Operating Income (EBIT)	74.17M	58.62M	37.52M	77.43M	9.42M	-87.8%
Non-Operating Items
Interest Income	1.69M	1.34M	3.17M	6.36M	3.11M	-51.1%
Interest Expense	(78.00K)	(72.00K)	(55.96M)	(73.39M)	(71.62M)	-2.4%
Other Income/Expenses (Net)	1.10M	1.59M	-59.56M	-91.73M	-1.14B	1145.5%
Income Before Tax	75.27M	60.21M	-22.04M	-14.30M	-1.13B	7821.1%
Income Tax Expense	(14.39M)	(11.90M)	(828.00K)	(4.88M)	(41.07M)	740.8%
Net Income	60.88M	48.31M	-22.87M	-9.42M	-1.09B	11491.6%
Per Share Metrics
Earnings Per Share (Basic)	$1	$0	$-0	$-0	$-5	11463.2%
Weighted Avg Shares Outstanding	106.50M	107.68M	188.88M	216.48M	216.89M	0.2%
Weighted Avg Shares Outstanding (Diluted)	107.12M	108.02M	188.88M	216.48M	216.89M	0.2%
EBITDA	96.31M	83.90M	122.30M	182.60M	-937.75M	-613.6%

Explore NEOG

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

NEOG in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Medical - Diagnostics & Research

Browse industry stocks →